SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?

Alexander, James L; Powell, Nick

Alexander, James L; Powell, Nick.

Alexander JL; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
Powell N; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: nicholas.powell@imperial.ac.uk.

Lancet Gastroenterol Hepatol ; 6(7): 528-529, 2021 07.

Article in English | MEDLINE | ID: covidwho-1243255

Subject(s)

COVID-19; Gastroenterology; Inflammatory Bowel Diseases; COVID-19 Vaccines; Humans; Inflammatory Bowel Diseases/drug therapy; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Gastroenterology / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2021 Document Type: Article Affiliation country: S2468-1253(21)00184-9

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google